表面特性与瑞卢无形固体分散的溶解行为之间的相关性及其药理动力学评估
Kanchan Bharti1, Abhishek Jha1, Manish Kumar1
1Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi, U.P. 221005, India.
Journal of pharmaceutical sciences
|October 16, 2024
概括
用水友性聚合物配制瑞卢 (RLZ) 的无形固体分散 (ASD) 改善了其溶解和生物可用性. 这些ASD增强了表面极性,增加了有效性并降低了大鼠的毒性,从而允许更低的治疗剂量.
科学领域:
- 制药科学 制药科学
- 材料科学 材料科学 材料科学
背景情况:
- 无形固体分散 (ASD) 对于提高水溶性较差的药物的生物可用性至关重要.
- 虽然研究了药物聚合物相互作用,但ASD的表面特性及其对溶解的影响仍未得到充分研究.
研究的目的:
- 为了研究瑞卢 (RLZ) 和其ASD与聚烯酸 (PAA) 和聚烯酸乙烯酸 (PVP VA) 的表面行为.
- 为了将表面性能变化与溶解增强和体内性能相关联.
主要方法:
- 用PAA和PVPVA.VA准备瑞卢 ASDs的制备.
- 使用X射线衍射 (XRD) 进行表征.
- 在老鼠中评估和溶解性,溶解性,表面湿透性 (接触角度),表面极性 (XPS),神经保护功效和肝毒性.
主要成果:
- XRD证实了单相同质系统.
- ASDs显著增加了RLZ的溶解性和溶解概况.
- 聚合物增强了表面极性和湿透性.
- 在体内研究表明,在推剂量时,疗效和毒性增加,这表明剂量降低的可能性.
结论:
- 聚合物诱导的表面特性变化,特别是极性,是提高RLZ ASDs溶解的关键.
- ASD配方提供了改善的治疗结果和降低的毒性,使更低的有效剂量.
相关概念视频
Factors Affecting Dissolution: Particle Size and Effective Surface Area
750
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
750
Factors Influencing Drug Absorption: Drug Dissolution
424
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
424
Factors Influencing Drug Absorption: Pharmaceutical Parameters
121
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
121
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
179
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
179
Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH
1.1K
Drug absorption within the gastrointestinal (GI) tract is a complex process influenced by several critical factors, including the site pH, the drug's dissociation constant (pKa), and the drug's lipophilicity. The GI tract exhibits a pH gradient, with an acidic environment in the stomach and a more alkaline environment in the small intestine. This pH variation directly affects the ionization state of drugs.
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
1.1K
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
289
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
289


